Skip to main content
Clinical Trials/NL-OMON35747
NL-OMON35747
Completed
Phase 4

Study evaluating ease of use, preference and satisfaction of two different Fluticason/salmeterol inhalers in asthma or COPD patients - Ease of use of two inhalers

Medisch Spectrum Twente0 sites110 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Asthma
Sponsor
Medisch Spectrum Twente
Enrollment
110
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Age \> 40 with stable COPD or asthma
  • 2\. Patients naïve to the study inhalers, Accuhaler/Diskus and Elpenhaler for at least 1 year
  • 3\. Patients agreeing on participating and signing the Informed Consent Form

Exclusion Criteria

  • 1\. Patients currently participating in another randomised clinical trial
  • 2\. Patients with body malformations or diseases affecting coordination and/or motor system
  • 3\. Patients unable to read product package instructions and answer patient reported questionnaires

Outcomes

Primary Outcomes

Not specified

Similar Trials